about
Modulating the Gut Microbiota Improves Glucose Tolerance, Lipoprotein Profile and Atherosclerotic Plaque Development in ApoE-Deficient MiceTesting the role of myeloid cell glucose flux in inflammation and atherosclerosisRosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages.Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneysMyeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes.VASP increases hepatic fatty acid oxidation by activating AMPK in mice.Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.Impact of Diabetes Mellitus.Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators.Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophagesEvidence stacks up that endothelial insulin resistance is a culprit in atherosclerosis.Inflammatory stimuli induce acyl-CoA thioesterase 7 and remodeling of phospholipids containing unsaturated long (≥C20)-acyl chains in macrophages.Monocyte Recruitment Versus Macrophage Proliferation in Atherosclerosis.A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome.High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 DiabetesIncreased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
P50
Q27332357-BB8FF076-AF1C-483E-B688-B8FD08AC9C00Q33612986-EAE276AD-3753-4B0A-93F0-FCA0D2B6A807Q33642252-5D581C58-64C6-4951-86F8-23A7C7090840Q33901965-03946927-4F89-4A1B-A9DE-71EAEE8DBB12Q36063184-800FD10C-C928-429E-9972-7890E109636AQ36867436-FBA79FEE-3747-4D0B-AB4D-70DC22C70C17Q36883079-2F205161-A06F-4963-B0A1-D978B7AA7951Q37149768-7DCA4430-F52C-4881-9867-AA474C1325C2Q38059912-E6AA70EA-5D56-4985-9104-63047C56302EQ38349580-5FB6264A-EB38-478C-B251-87594E86F466Q39454322-3DD44A0B-7EC1-4BCC-A9C3-EE4BE913E258Q42867693-96E90C9E-F972-4665-82E6-5BA4E2E04FC2Q46381890-DA8215CE-86E5-42A7-A945-07E873CF9A44Q47598516-992AF6DC-5021-4342-8C88-49535DF817CEQ52684469-6D87EBA6-B6D4-4461-9DDC-23FDF0AD6989Q90615969-DFE64F81-9340-40DA-A3B2-12FE6F94F61AQ91795685-58EA3CE3-4A11-41FA-B9A1-96D9C5577586
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jenny E Kanter
@ast
Jenny E Kanter
@en
Jenny E Kanter
@es
Jenny E Kanter
@nl
Jenny E Kanter
@sl
type
label
Jenny E Kanter
@ast
Jenny E Kanter
@en
Jenny E Kanter
@es
Jenny E Kanter
@nl
Jenny E Kanter
@sl
prefLabel
Jenny E Kanter
@ast
Jenny E Kanter
@en
Jenny E Kanter
@es
Jenny E Kanter
@nl
Jenny E Kanter
@sl
P106
P21
P31
P496
0000-0003-3212-772X